• Explore /
  • Poster
  • / <span>M<span>etronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with <span>HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME).</span></span></span>

Metronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME).

Abstract Poster

Authors

null

Vanessa Petry

Instituto do Cancer do Estado de São Paulo, Univer

Vanessa Petry , Alessandro Leal , Roberto Arai , Simone Marinho , Marcelo Paiva , Jose Piato , Marcio Rosa , Paulo Hoff , Max Mano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Breast Cancer Symposium

Session Type

Poster Session

Session Title

General Poster Session A

Track

Risk Assessment, Prevention, Detection, and Screening

Sub Track

Management of Node-Positive Disease

Clinical Trial Registration Number

NCT01329640 and NCT01329627

Citation

J Clin Oncol 30, 2012 (suppl 27; abstr 197)

DOI

10.1200/jco.2012.30.27_suppl.197

Abstract #

197

Poster Bd #

E6

Abstract Disclosures

Similar Posters

First Author: G. Somlo

First Author: Alexandra Thomas

First Author: Yifan Tu

First Author: Sierra Mi Li